All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @trensetta860 on TikTok · 32s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @trensetta860's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00There's my body right now. I'm 31
  2. 0:046-2. I don't really got no muscles like that. I mean
  3. 0:09I'm decently strong I guess
  4. 0:12But there's my body
  5. 0:14This is all I got for a mirror right now and the bathroom currently doing renovations on as you can see
  6. 0:20But the only thing I'm taking right now is to zepatine
  7. 0:24So I mean this is what I look like for right now. I'll update you guys in the future

TRT day one videos: what the science says about realistic expectations

TREN-SETTA💪

TikTok creator

1.7K viewsWatch on TikTok

Quick answer

The creator is a 31-year-old male starting TRT and concurrently taking tirzepatide, a dual GIP/GLP-1 receptor agonist with significant evidence for weight reduction in adults with obesity. Any body composition changes documented in future updates will reflect the combined effects of both compounds plus lifestyle factors, making it difficult to isolate testosterone's contribution. TRT's body composition effects in hypogonadal men are well-documented but modest compared to the fat loss magnitude seen in SURMOUNT-1 trial data for tirzepatide.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TRT day one videos: what the science says about realistic expectations, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

TRT day one videos: what the science says about realistic expectations should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "TRT day one videos: what the science says about realistic expectations" from TREN-SETTA💪. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is a 31-year-old male starting TRT and concurrently taking tirzepatide, a dual GIP/GLP-1 receptor agonist with significant evidence for weight reduction in adults with obesity.

The reason this review is not generic is the source wording and the canonical claim label "trt weightlossmotivation trt fatloss gym lowt this is day one of." In this clip, the useful excerpt is: "There's my body right now." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Tirzepatide Once Weekly for the Treatment of Obesity (2022), Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (2024), and Tirzepatide for Obesity Treatment and Diabetes Prevention (2025), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

TRT in confirmed hypogonadal men produces roughly 1-3 kg fat mass reduction and comparable lean mass gain, according to a 2013 meta-analysis by Kapoor et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is a 31-year-old male starting TRT and concurrently taking tirzepatide, a dual GIP/GLP-1 receptor agonist with significant evidence for weight reduction in adults with obesity.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is a 31-year-old male starting TRT and concurrently taking tirzepatide, a dual GIP/GLP-1 receptor agonist with significant evidence for weight reduction in adults with obesity. Any body composition changes documented in future updates will reflect the combined effects of both compounds plus lifestyle factors, making it difficult to isolate testosterone's contribution. TRT's body composition effects in hypogonadal men are well-documented but modest compared to the fat loss magnitude seen in SURMOUNT-1 trial data for tirzepatide.
  • Tirzepatide (SURMOUNT-1 trial, Jastreboff et al. 2022, NEJM) produces up to 20.9% body weight reduction over 72 weeks, making it likely the primary fat-loss driver in this stack, not testosterone.
  • TRT in confirmed hypogonadal men produces roughly 1-3 kg fat mass reduction and comparable lean mass gain, according to a 2013 meta-analysis by Kapoor et al. in the European Journal of Endocrinology.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Tirzepatide (SURMOUNT-1 trial, Jastreboff et al. 2022, NEJM) produces up to 20.9% body weight reduction over 72 weeks, making it likely the primary fat-loss driver in this stack, not testosterone.
  • TRT in confirmed hypogonadal men produces roughly 1-3 kg fat mass reduction and comparable lean mass gain, according to a 2013 meta-analysis by Kapoor et al. in the European Journal of Endocrinology.
  • The American Urological Association guidelines (Mulhall et al., 2018) specify TRT is indicated for men with serum testosterone below ~300 ng/dL plus symptoms, not as a general body composition tool.
  • Tirzepatide is a prescription-only dual GIP/GLP-1 receptor agonist requiring physician oversight. It is not interchangeable with over-the-counter peptide supplements marketed online.
  • Body composition changes from TRT typically become measurable at 3-6 months, meaning day-one videos have no predictive value for outcome claims.
  • When multiple compounds and lifestyle changes occur simultaneously, attributing results to any single agent is scientifically unreliable, a common problem in social media transformation content.
  • Viewers should not interpret this creator's future results as typical or replicable without knowing their confirmed testosterone levels, diet, training, and tirzepatide dosing protocol.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @trensetta860 actually say?

Honestly, not much, and that's worth noting. The creator shows their physique on day one of TRT, describes themselves as 6'2", 31 years old, "decently strong" but without significant muscle mass. The only specific claim is that "the only thing I'm taking right now is tirzepatide." They promise future updates on side effects and body composition. No wild testosterone promises, no broscience about gear cycles. This is a baseline video, and it's pretty straightforward.

That restraint matters. TRT content on TikTok tends toward either fear-mongering or hype. This creator is doing neither. They're documenting a starting point. The problem is what's left unsaid: why they're on TRT, what their levels are, who prescribed it, and what tirzepatide is doing alongside it.

Does the science back this up?

There's nothing to fact-check yet in terms of specific claims, but the combination of TRT and tirzepatide is worth examining because it's increasingly common in weight loss clinics and the data is genuinely interesting.

Testosterone replacement in hypogonadal men does produce measurable changes in body composition. A 2013 meta-analysis by Kapoor et al. in the European Journal of Endocrinology found TRT reduced fat mass and increased lean mass in men with confirmed low testosterone. The effects are real but modest without exercise, typically 1-3 kg of fat loss and comparable lean mass gain over several months.

Tirzepatide is a dual GIP/GLP-1 receptor agonist. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed up to 20.9% body weight reduction in non-diabetic adults with obesity over 72 weeks. That's a much stronger weight loss signal than TRT alone provides. If this creator loses significant body fat, tirzepatide deserves most of the credit, not testosterone.

What did they get wrong (or right)?

They got the baseline documentation right. Starting a before video without making claims is actually the responsible move. Too many TRT creators front-load promises they can't keep or attribute every change to testosterone when they're also training harder, eating less, and sometimes using other compounds.

What's missing, and this isn't unique to this creator, is any acknowledgment that tirzepatide is doing heavy lifting in this stack. If the video caption says "#fatloss" and "#trt" but tirzepatide is the primary fat-loss agent here, viewers following for TRT inspiration may be getting an incomplete picture. That's not a lie, but it is a framing issue.

Also worth saying plainly: TRT does not cause dramatic fat loss in men with normal or borderline testosterone levels. The body composition benefits are real but are significantly amplified by caloric deficit, resistance training, and in this case, a GLP-1 class drug. Attributing future results solely to testosterone would be misleading.

What should you actually know?

If you're considering TRT based on content like this, the most important thing is whether you have confirmed hypogonadism, meaning a serum total testosterone below roughly 300 ng/dL on two morning measurements, combined with clinical symptoms. The American Urological Association guidelines (Mulhall et al., 2018) are clear that TRT is not a general wellness or body composition intervention for men with normal levels.

Tirzepatide is a prescription medication approved for type 2 diabetes (Mounjaro) and obesity (Zepbound). It is not a supplement. It requires medical supervision, particularly because it can affect muscle mass loss alongside fat loss, which is why some clinicians pair it with testosterone or resistance training protocols.

  • Do not start TRT or tirzepatide without confirmed lab work and a prescribing physician.
  • Expect body composition changes to take 3-6 months to become visible.
  • Results in TikTok transformation content are almost never attributable to a single compound.

Bottom line verdict

This video is fine. It's a day-one baseline with no harmful claims. The creator mentions tirzepatide, which shows more transparency than most. But anyone watching this for TRT motivation should understand that they are likely watching a tirzepatide transformation as much as a testosterone one. That distinction matters when you're deciding what to ask your doctor about.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

TREN-SETTA💪 · TikTok creator

1.7K views on this video

#weightlossmotivation #trt #fatloss #gym #lowT this is day one of taking TRT will give updates on any side effects and body composition changes.

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about tirzepatide (surmount-1 trial, jastreboff et al. 2022, nejm) produces up?

Tirzepatide (SURMOUNT-1 trial, Jastreboff et al. 2022, NEJM) produces up to 20.9% body weight reduction over 72 weeks, making it likely the primary fat-loss driver in this stack, not testosterone.

What does the video say about trt in confirmed hypogonadal men produces roughly 1-3 kg fat?

TRT in confirmed hypogonadal men produces roughly 1-3 kg fat mass reduction and comparable lean mass gain, according to a 2013 meta-analysis by Kapoor et al. in the European Journal of Endocrinology.

What does the video say about the american urological association guidelines (mulhall et al., 2018) specify?

The American Urological Association guidelines (Mulhall et al., 2018) specify TRT is indicated for men with serum testosterone below ~300 ng/dL plus symptoms, not as a general body composition tool.

What does the video say about tirzepatide?

Tirzepatide is a prescription-only dual GIP/GLP-1 receptor agonist requiring physician oversight. It is not interchangeable with over-the-counter peptide supplements marketed online.

What does the video say about body composition changes from trt typically become measurable at 3-6?

Body composition changes from TRT typically become measurable at 3-6 months, meaning day-one videos have no predictive value for outcome claims.

When multiple compounds and lifestyle changes occur simultaneously, attributing results to any single agent is scientifically unreliable, a common problem in social media transformation content?

When multiple compounds and lifestyle changes occur simultaneously, attributing results to any single agent is scientifically unreliable, a common problem in social media transformation content.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by TREN-SETTA💪, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.